VIRCELL
Vircell is a privately held Spanish biotechnology company that develops and manufactures ready-to-use diagnostic reagents and instruments for human infectious disease testing, selling through direct sales teams to clinical laboratories in more than 90 countries.
- Company typePrivate
- Founded1994
- HeadquartersGranada, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What VIRCELL does
Vircell, S.L. is a privately held Spanish biotechnology company headquartered in the Parque Tecnológico de la Salud in Granada, founded in the mid-1990s, that develops, manufactures, and sells ready-to-use diagnostic reagents for human infectious diseases. Its portfolio is organized into two divisions — Vircell Microbiologists (serology) and Vircell Molecular (molecular diagnostics) — covering more than 500 catalog references for the detection of bacteria, viruses, parasites, and fungi across 15+ disease categories using ELISA, chemiluminescence, direct and indirect immunofluorescence, immunocapture, real-time PCR, PCR controls, and cell culture techniques.
The serological line is anchored by the VirClia® Monotest reagent family and the VirClia® Lotus fully automated continuous-load random-access CLIA analyzer capable of running 90+ infectious markers in monotest format. The molecular line comprises the VIRCOM real-time PCR kits, VIRPLEX extraction and RT-PCR kits, VIRCOM MINILAB compact instrument, and the AMPLIRUN® line of independent molecular controls. Registered trademarks (VirClia®, AmpliRun®, Brucellacapt®, VIRCOM, VIRPLEX) and specialized products such as Brucellacapt® for brucellosis immunocapture testing define a number of defensible niche positions.
Vircell operates a B2B sales-led go-to-market, selling reagents and instruments directly to clinical microbiology and molecular diagnostic laboratories through dedicated national and international commercial teams, reaching more than 90 countries across five continents. The company is ISO 13485:2016 certified (TÜV SÜD), holds Esquema Nacional de Seguridad certification, and is in the process of certifying its catalog under the EU IVDR, with Class A non-sterile products compliant since May 2022 and Class B and C products certified as of October 2024. No pricing is publicly disclosed and no revenue, funding, or customer concentration data is available in the source material.
VIRCELL firmographics
Firmographics- Name
- VIRCELL
- Legal name
- Vircell, S.L.
- Website
- https://vircell.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Vircell is a privately held Spanish biotechnology company that develops and manufactures ready-to-use diagnostic reagents and instruments for human infectious disease testing, selling through direct sales teams to clinical laboratories in more than 90 countries.
- Ownership category
- akta.pro rank
VIRCELL industry classification
Industry- Product category
- In Vitro Diagnostics (IVD) Reagents and Kits
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
Keywords
Where VIRCELL is headquartered
LocationHeadquarters
- HQ city
- Granada
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
VIRCELL business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Reagents and Kits: Vircell generates revenue through the sale of ready-to-use diagnostic reagents for serological and molecular techniques used in human infectious disease diagnosis. The product portfolio includes over 500 catalog references covering bacteria, viruses, parasites, and fungi detection.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
VIRCELL product offering
Product offeringCore offering
Vircell, S.L. develops, manufactures, and sells ready-to-use diagnostic reagents, kits, and instruments for the detection of infectious diseases in humans. The portfolio spans two divisions — Vircell Microbiologist (serological techniques: ELISA, chemiluminescence, indirect and direct immunofluorescence, immunocapture, rapid tests, cell culture, transport media) and Vircell Molecular (Real Time PCR kits, extraction reagents, independent molecular controls, and compact PCR instruments). The company offers more than 500 catalog references covering bacteria, viruses, parasites, and fungi, distributed to clinical laboratories in over 90 countries.
Product overview
VIRCELL is a biotechnology company specializing in the development and production of ready-to-use diagnostic reagents for infectious diseases in humans. The portfolio consists of two main divisions: Vircell Microbiologist (serological products) and Vircell Molecular (molecular biology products). The serological line includes VirClia® Monotest, VirClia® Lotus automated CLIA analyzer, ELISA, IFA (Indirect Immunofluorescence), DFA (Direct Immunofluorescence), Brucellacapt®, Rose Bengal, rapid tests, cell lines, and transport media. The molecular line includes VIRCOM PCR kits, VIRPLEX extraction and RT-PCR kits, VIRCOM MINILAB, AmpliRun® molecular controls (including AmpliRun® Total), and molecular instruments. The company offers over 500 product references covering bacteria, viruses, parasites, and fungi detection using serological and molecular techniques. Products are available in over 90 countries worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- VirClia® Monotest: CLIA chemiluminescence monotest for infectious disease diagnosis
- VirClia® Lotus
- AMPLIRUN®
- AMPLIRUN® Total
- VIRCOM
- VIRPLEX
- Brucellacapt®
Products and services
- VirClia® Monotest
- VirClia® Lotus
- ELISA Reagents
- IFA (Indirect Immunofluorescence) Reagents
- DFA (Direct Immunofluorescence) Reagents
- Brucellacapt®
- Rosa de Bengala (Rose Bengal)
- Pruebas Rápidas (Rapid Diagnostic Tests)
- VIRCOM PCR Kits
- VIRPLEX RT-PCR Kits
- VIRPLEX Extraction Reagents
- AmpliRun® Molecular Controls
- AmpliRun® Total Molecular Controls
- VIRCOM MINILAB
- Líneas Celulares (Cell Lines)
- Medios de Transporte (Viral Transport Media)
- Instrumentos VirClia®
- Instrumentos Biología Molecular (Molecular Biology Instruments)
Companies that use VIRCELL
Customer profileSegments1 record
Ideal customer profiles2 records
VIRCELL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
VIRCELL partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TÜV SÜD Product Service GmbHcoreTÜV SÜD Product Service GmbH serves as Vircell's Notified Body for IVDR conformity assessment and ISO 13485 quality management system certification. As of October 18, Vircell obtained certification necessary to CE-mark Class B and C products under IVDR through this partnership.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
VIRCELL competitors and assessment
Company assessmentDirect peers
- bioMérieux: Global leader in microbiology and infectious disease diagnostics, offering serology, molecular, and culture-based IVD reagents and instruments to clinical laboratories. Highly comparable to Vircell across product category, customer base, and commercial model, though materially larger and more diversified.
- Bio-Rad Laboratories: Established IVD manufacturer with a broad infectious disease serology and molecular controls portfolio serving clinical laboratories worldwide. Direct overlap with Vircell in ELISA, molecular controls, and quality assurance reagents for microbiology.
- DiaSorin: Specialist in CLIA-based serological diagnostics with a strong infectious disease menu and proprietary LIAISON analyzer family. Closely comparable to Vircell on the VirClia Lotus / chemiluminescence serology side, serving the same clinical lab customers.
- Meridian Bioscience: US-based specialty IVD company focused on gastrointestinal, respiratory, and other infectious disease diagnostics, with both molecular and immunoassay products. Comparable to Vircell as a mid-sized infectious-disease-focused reagent manufacturer.
- ELITech Group: European-headquartered specialty IVD company producing molecular diagnostics kits (PCR) and clinical chemistry reagents for clinical laboratories. Closely comparable mid-sized competitor with overlapping customer base and product focus.
- R-Biopharm: German specialty diagnostics manufacturer offering IVD reagents across clinical chemistry, microbiology, and food/feed testing, including PCR-based infectious disease kits. Comparable mid-sized European IVD reagent company with similar product breadth and lab customer focus.
Broad incumbents
- QuidelOrtho: Large diversified diagnostics player offering infectious disease rapid tests, molecular assays, and specialty immunoassays. Operates across broader portfolios than Vircell but is a direct competitor in select infectious disease serology and rapid test categories.
- Hologic: Major molecular diagnostics company with a strong infectious disease franchise (e.g., Panther system, Aptima assays). A competitor in the molecular infectious disease IVD space where Vircell's VIRCOM and VIRPLEX kits also compete for lab adoption.
- Sekisui Diagnostics: Global IVD manufacturer with serology, clinical chemistry, and rapid test portfolios serving clinical laboratories. Competes with Vircell in infectious disease serology and rapid testing, with a larger overall portfolio and broader commercial reach.
Others
- Tecan: Laboratory automation and detection instrument manufacturer whose readers and automated platforms can be used alongside IVD reagent workflows. Comparable to Vircell as a laboratory instrumentation supplier to the same clinical lab customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
VIRCELL social profiles
Digital presenceVIRCELL compliance and trust
Trust signalCompliance3 records
VIRCELL financial estimates
Financial estimateRevenue estimate
Valuation estimate
VIRCELL leadership team
Management profileNumber of profiles
VIRCELL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VIRCELL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VIRCELL
What does VIRCELL do?
Vircell, S.L. develops, manufactures, and sells ready-to-use diagnostic reagents, kits, and instruments for the detection of infectious diseases in humans. The portfolio spans two divisions — Vircell Microbiologist (serological techniques: ELISA, chemiluminescence, indirect and direct immunofluorescence, immunocapture, rapid tests, cell culture, transport media) and Vircell Molecular (Real Time PCR kits, extraction reagents, independent molecular controls, and compact PCR instruments). The company offers more than 500 catalog references covering bacteria, viruses, parasites, and fungi, distributed to clinical laboratories in over 90 countries.
Is VIRCELL a public or private company?
VIRCELL is a private company. It is classified as unknown and is currently operating.
When was VIRCELL founded?
VIRCELL was founded in 1994. It employs 101 to 250 people.
Where is VIRCELL based?
VIRCELL is headquartered in Granada, Spain, in the Europe region.
How does VIRCELL make money?
One revenue line is on record: diagnostic Reagents and Kits.
Who are VIRCELL's main competitors?
Direct peers on record are bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, ELITech Group and R-Biopharm. Broad incumbents are QuidelOrtho, Hologic and Sekisui Diagnostics. Tecan is listed as an others.
Does VIRCELL have an API?
No public API is recorded for VIRCELL.
What industry is VIRCELL in?
VIRCELL's product category is In Vitro Diagnostics (IVD) Reagents and Kits. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 325413 and its SIC code is 2835.